Skip to content

Medivive

Active Private limited companyfounded 2015active for 11 yearsSint-Eloois-Winkelsestraat 79, 8800 RoeselareKBO/BCE: BE 0640.993.123

Lifetime

11 annual accounts with figures on one time axis
peak of €653,307 in 2024
€609,623▼ 6.7%
peak of €433,872 in 2023
€395,158▼ 7.3%
peak of €671,110 in 2020
€263,758▼ 41.0%
€1.8m▲ 9.6%
Board3 names since 2015
2 directors and 1 other
Documentsfilings and deeds
22-07-20269 days before the deadline
2025micro format
Dividend €578,156Equity from €446,756 to €263,758Cash from €376,080 to €540,584

Key points

from the 2025 annual accounts

Equity

€263,758 from €671,110 in 2020

Equity fell by 61% in 5 years.

Debts

€1.8m 87% of the balance sheet
Financial debts 32%Suppliers 0%Taxes and wages 5%Other 63%

Of this, €1.2m falls due within a year.

Position in the sector

€395,158

Higher net result than 95% of companies in human health. Sector median €59,541 · 21,324 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,609 companies had the same profile as Medivive has now. Each dot stands for 7 companies, two years later.

96.8%
were still trading
2.1%
stopped another way
1.0%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,912 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,609 companies, not a prediction for Medivive. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager, since 14-10-2015
Director, since 14-10-2015
  • founderdeed of 19-10-2015
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0640993123
Company renamed from DOKTER THOMAS RYCKAERT to Medivive changes role from manager to statutory director · appointed as statutory director · Director discharge: · General meeting of 03-05-2023 · Gazette deed
Incorporation Founding capital of €18,600, 120 shares · Founded by · appointed as manager · published on 19-10-2015 · Gazette deed
First establishment Dokter Thomas Ryckaert, Sint-Eloois-Winkelsestraat 79, Roeselare
All 18 events

Comparable companies

same main activity, similar in size and age
Company
Medivive Roeselare €2.1m €609,623 12.7% -
Dr. Pieter Volcke, fysiotherapeut Oostkamp €1.9m €585,002 29.6% -
Harm Arentsen Urologie Bruges €1.9m €577,599 99.2% -
Cabinet Mistrih Woluwe-Saint-Pierre €1.9m €634,925 55.2% 1
DR. CASTILLE, ANESTHESIST Destelbergen €2.1m €657,092 93.1% 0
OOGCHIRURGIE DR. VAN SLYCKEN -DR.CANDAELE Ghent €1.9m €559,026 31.2% 2.3
Vunjo Kampenhout €2.1m €666,481 77.8% -

These companies have the same main activity as Medivive: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.9m and €2.1m, founded between 2014 and 2017.

Official details

Source: KBO
Status
Active since 15-10-2015Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment unit
2.246.802.9818800 Roeselare, since 15-10-2015
Financial year end
31 December
Peppol
Reachable since 05-01-2026
Company details

Annual accounts 2025

≈ €920,000estimated
€2.1m▼ 1.1%
Filing
Filed on 22-07-2026, 9 days before the end of the filing period
Financials

Insights on Medivive

Medivive files the micro format. That format states no turnover. The gross margin rose from €219,263 in 2015 to €609,623 in 2025.

The balance sheet grew most from 2018 to 2020 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Medivive

What is the company number of Medivive?
The company number of Medivive is 0640.993.123. The VAT number is the same number with BE in front: BE 0640.993.123.
Where is Medivive based?
The registered office is at Sint-Eloois-Winkelsestraat 79, 8800 Roeselare.Company details
What does Medivive do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Medivive?
Medivive is a private limited company (BV).
When was Medivive founded?
Medivive was founded on 15-10-2015.
Is Medivive still active?
Yes, Medivive is an active enterprise in the KBO register.
What is the turnover of Medivive?
The turnover in financial year 2025 is ≈ €920,000. This figure is estimated from the gross margin of €609,623 and 31 comparable companies (NACE 86220). It probably lies between €810,000 and €1.3m.Financials
Is Medivive profitable?
In financial year 2025, Medivive made a profit of €395,158.
Where can I find the annual accounts of Medivive?
Medivive filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Medivive due?
Medivive must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.